Brain Health Made
Accessible

Objective
Brain Health Diagnosis, at Any
Point of Care

Making an Impact
Delphi-MD empowers neurologists, point of care physicians, healthcare systems and preventative care programs with real time, accurate clinical insights for early diagnosis of brain abnormalities. Delphi-MD produces actionable recommendations to help patients receive better care and reduce the massive financial burden associated with brain health care.

Physicians

Healthcare Systems

Health Plans
A Wide Range of Diagnostic Value
Delphi-MD was granted FDA Breakthrough designation status twice, for 2 clinical indications.
The first is for the detection of early functional and structural brain abnormalities that indicate the early progression of stroke and dementia. And the second for accurately diagnosing NPH (Normal Pressure Hydrocephalus) and predicting the effectiveness of a shunt implant treatment (VPS).

Normal Pressure Hydrocephalus

Vascular Dementia

Alzheimer's Disease

Stroke

Lewy Body Dementia

Parkinson's Disease

Traumatic Brain Injury
Why Delphi-MD?

Scientifically
validated

Objective reading of brain network health

Early and differential
diagnosis

Easy to use in any
clinical setting

Highly accurate,
real-time results

Provides a clinical
actionable report

Safe, non-invasive and
radiation free

Accessible and
cost-effective
How Does It Work?
· Trusted Partners ·
Confidence Through Evidence

Early diagnosis of Dementia
Frontiers 2021
Delphi enables the early diagnosis of Dementia. Fogel et al.; Dementia and Neurodegeneration.

Delphi detects white matter changes indicating StrokeTBI
Delphi-MD and aging
Frontiers 2019
Delphi Diagnosis of Abnormal Aging. Zifman et al; Frontiers in Aging Neuroscience.